Breast cancer is a complex disease involving numerous pathways, making effective treatment quite challenging. Among the current scenario, drug repurposing serves as one of …
T Tian, Y Li, Y Yu, X Cao, M Li… - European Journal of …, 2023 - Wiley Online Library
Background. Primary angiosarcoma of the breast (PAS) is a rare aggressive tumor with no standardized treatment. The aim of this study was to investigate the characteristics of all …
Y Zhou, YW Sun, XY Liu, DH Shen - World Journal of Clinical …, 2023 - ncbi.nlm.nih.gov
BACKGROUND Angiosarcoma (AS) is a rare and highly aggressive soft tissue disease that most commonly arises in deep soft tissues. There are only a few reported cases of AS …
S Rehman, A Harikrishna, A Silwal, BR Sumie… - Annals of Diagnostic …, 2024 - Elsevier
Ovarian angiosarcoma (OA) is rare, with only sporadic cases reported in English literature. We performed a systematic review of cases published in the PubMed, Science Direct, and …
Y Zhu, S Nakamoto, T Tsukioki… - Chinese Clinical …, 2024 - cco.amegroups.org
Methods: A literature review in agreement with the PRISMA protocol was conducted. Medline and Cochrane databases were searched for English articles on PBA patients in …
M Ozsen, SAV Polatkan, U Yalcınkaya… - Clinical and …, 2024 - Springer
Objective While the majority of breast neoplasms originate from epithelial cells, a rare part of them originate from mesenchymal breast tissue. This study aims to present the …
KM Jackson, JG Grumley - Current Breast Cancer Reports, 2024 - Springer
Abstract Purpose of Review Although rare, breast angiosarcoma imparts poor outcomes relative to other breast malignancies. Here, we review the current literature focusing on …
AI Ciuvică, TA Georgescu… - … of Morphology and …, 2024 - pmc.ncbi.nlm.nih.gov
Angiosarcoma represents a group of rare tumors originating from vascular and lymphatic endothelial cells, characterized by marked aggressiveness, rapid growth and poor clinical …